Hereditary spastic paraplegia associated with dopa-responsive parkinsonism

Area of Science:

• Neurology
• Movement Disorders

Background:

• Hereditary spastic paraplegia (HSP) is a group of inherited neurological disorders.
• Parkinsonian features can co-occur with HSP, complicating diagnosis and treatment.
• Levodopa is a primary treatment for Parkinson's disease symptoms.

Observation:

• A 47-year-old patient presented with hereditary spastic paraplegia and parkinsonian features.
• Initial levodopa treatment resulted in significant neurological and quality of life improvements.
• Long-term levodopa therapy led to the development of motor fluctuations and dyskinesias.

Findings:

• Levodopa provided substantial initial benefit for this patient's complex neurological condition.
• Amantadine treatment effectively managed and resolved levodopa-induced dyskinesias.
• This case highlights the potential for managing motor complications in HSP patients.

Implications:

• Levodopa can be beneficial in managing parkinsonian features in HSP, but requires careful monitoring.
• Amantadine is a viable therapeutic option for dyskinesias associated with levodopa treatment in this population.
• Further research into long-term management strategies for co-occurring HSP and parkinsonism is warranted.